Keywords
Prevalence
Neurobiologic factors
Environmental enrichment
Dependencias
Prevalencia
Factores neurobiológicos
Enriquecimiento ambiental
How to Cite
Abstract
Introduction: It has been estimated that 80% to 90% of the population worldwide has ever consumed psychoactive substances (PAS), but only 15% will develop addiction. The goal of the current essay is to describe concisely the epidemiological background, the clinical foundations, and neurobiological mechanisms of addiction. Finally, it will briefly examine some environmental strategies aimed to prevent and/or treat addiction. Addiction is not a simple vice consequence of laziness or lack of character, but a neuropsychiatric disorder that must be recognized as such. Proposal: To attain this ultimate goal, the etiological factors and the neurobiological mechanisms of addiction must be revealed and disseminated. Arguments for discussion: All PAS directly or indirectly activate the mesolimbic dopaminergic system, which –after repeated intake– sensitizes and desensitizes the motivational and the hedonic system, respectively. This phenomenon causes PAS to be consumed more frequently and at higher doses despite their effects being progressively less rewarding. Consequently, the physical and emotional distress derived from the withdrawal syndrome exacerbates the compulsive PAS intake, while the completely loss of control results from impairments in the executive functions and the prefrontal cortex. Conclusions: Addiction is a brain disease induced by the chronic consumption of PAS combined with neurobiological and psychosocial risk factors. Exposure social contact, physical exercise, and sensory-cognitive stimulation may constitute a highly effective strategy for preventing and treating addiction and improving mental health as well.
References
Ahumada-Cortez, J. G., Gámez-Medina, M. E. y Valdez-Montero, C. (2017). El consumo de alcohol como problema de salud pública. Ra Ximhai, 13(2), 13-24. doi: 10.35197/rx.13.02.2017.01.ja
American Psychiatric Association - APA. (2013). Diagnostic and Statistical Manual of Mental Disorders DSM-V (5th ed. --.). Washington DC: American Psychiatric Association.
Berridge, K. C. y Robinson, T. E. (2016). Liking, wanting, and the incentive-sensitization theory of addiction. The American Psychologist, 71(8), 670-679. doi: 10.1037/amp0000059
Brenes, J. C., Fornaguera, J. y Sequeira-Cordero, A. (2020). Environmental enrichment and physical exercise attenuate the depressive-like effects induced by social isolation stress in rats. Frontiers in Pharmacology, 11(804). doi: 10.3389/fphar.2020.00804
Brenes, J. C., Heyse, N., Álvarez, G. y Schwarting, R. K. W. (2013). Effects of exercise reward on spontaneous and amphetamine-induced appetitive ultrasonic vocalizations in rats. Society for Neuroscience, 43rd Annual Meeting, San Diego, USA.
Brenes, J. C., Urquijo, M. F., Wöhr, M., Höglinger, G. U. y Schwarting, R. K. W. (2011). Differential effect of physical and social environmental enrichment on ultrasonic vocalizations in rats. Society for Neuroscience, 41st Annual Meeting, Washington, USA.
Brugal, T., Barbaglia, M., Parés, O. y Bosque, M. (2018). COPOLAD. http://copolad.eu/es/actividades/ficha/26
Creed, M. C., Ntamati, N. R. y Tan, K. R. (2014). VTA GABA neurons modulate specific learning behaviors through the control of dopamine and cholinergic systems. Frontiers in Behavioral Neuroscience, 8(8). doi: 10.3389/fnbeh.2014.00008
D'Souza, M. S. (2015). Glutamatergic transmission in drug reward: implications for drug addiction. Frontiers in Neuroscience, 9, 404. doi: 10.3389/fnins.2015.00404
Edwards, S. y Koob, G. F. (2013). Escalation of drug self-administration as a hallmark of persistent addiction liability. Behavioural Pharmacoly, 24(5-6), 356-362. doi: 10.1097/FBP.0b013e3283644d15
Fischer, A. G. y Ullsperger, M. (2017). An Update on the Role of Serotonin and its Interplay with Dopamine for Reward. Frontiers in Human Neuroscience, 11, 484. doi: 10.3389/fnhum.2017.00484
Fitzgerald, P. J. (2013). Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine. Substance Abuse: Research and Treatment, 7, 171-183. doi: 10.4137/SART.S13019
Galaj, E., Barrera, E. D. y Ranaldi, R. (2020). Therapeutic efficacy of environmental enrichment for substance use disorders. Pharmacology Biochemistry and Behavior, 188, 172829. doi: 10.1016/j.pbb.2019.172829
GBD 2016 Alcohol Collaborators. (2018). Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 392(10152), 1015-1035. doi: 10.1016/S0140-6736(18)31310-2
Goldstein, R. Z. y Volkow, N. D. (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nature Reviews. Neuroscience, 12(11), 652-669. doi: 10.1038/nrn3119
Instituto Costarricense sobre Drogas (ICD). (2019). Perfiles personales y sociodemográficos de las personas que reciben tratamiento en Organizaciones no Gubernamentales autorizadas por el IAFA en Costa Rica. San José, Costa Rica: Instituto Costarricense sobre Drogas.
Instituto Costarricense sobre Drogas (ICD). (2021). Informe de Situación Nacional sobre Drogas y Actividades Conexas. San José, Costa Rica: Instituto Costarricense sobre Drogas.
Instituto sobre Alcoholismo y Farmacodependencia (IAFA). (2018). VI Encuesta Nacional sobre Consumo de Drogas en Población General 2015. San José, Costa Rica: Instituto sobre Alcoholismo y Farmacodependencia.
Instituto sobre Alcoholismo y Farmacodependencia (IAFA). (2019). V Encuesta Nacional: Sobre Consumo de Sustancia Psicoactivas en Población de Educación Secundaria, 2018. Costa Rica: Instituto sobre Alcoholismo y Farmacodependencia.
Kalivas, P. W. y O'Brien, C. (2008). Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology, 33(1),166-180. doi: 10.1038/sj.npp.1301564
Koob, G. F. (2013). Addiction is a Reward Deficit and Stress Surfeit Disorder. Frontiers in Psychiatry, 4, 72. doi: 10.3389/fpsyt.2013.00072
Koob, G. F. y Le Moal, M. (2005). Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nature Neuroscience, 8(11),1442-1444. doi: 10.1038/nn1105-1442
Koob, G. F. y Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760-773. doi: 10.1016/S2215-0366(16)00104-8
Kováč, L. (2012). The biology of happiness. Chasing pleasure and human destiny. EMBO Reports, 13(4), 297-302. doi: 10.1038/embor.2012.26
Kringelbach, M. L. y Berridge, K. C. (2010). The Neuroscience of Happiness and Pleasure. Social Research, 77(2), 659-678. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008658/pdf/nihms257673.pdf
Linke, S. E. y Ussher, M. (2015). Exercise-based treatments for substance use disorders: evidence, theory, and practicality. The American Journal of Drug and Alcohol Abuse, 41(1), 7-15. doi: 10.3109/00952990.2014.976708
Lopez-Quintero, C., Pérez de los Cobos, J., Hasin, D. S., Okuda, M., Wang, S., Grant, B. F. y Blanco, C. (2011). Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence, 115(1-2), 120-130. doi: 10.1016/j.drugalcdep.2010.11.004
Lu, H. C. y Mackie, K. (2016). An Introduction to the Endogenous Cannabinoid System. Biological Psychiatry, 79(7), 516-525. doi: 10.1016/j.biopsych.2015.07.028
Madsen, H. B., Brown, R. M. y Lawrence, A. J. (2012). Neuroplasticity in addiction: cellular and transcriptional perspectives. Frontiers in Molecular Neuroscience, 5, 99. doi: 10.3389/fnmol.2012.00099
Morgan, J. A., Corrigan, F. y Baune, B. T. (2015). Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations. Journal of Molecular Psychiatry, 3(1), 3. doi: 10.1186/s40303-015-0010-8
Observatorio Europeo de las Drogas y las Toxicomanías (OEDT). (2021). Informe Europeo sobre Drogas 2021: Tendencias y novedades. Luxemburgo: Oficina de Publicaciones de la Unión Europea.
Oganización Panamericana de la Salud (OMS). (2021). Abuso de sustancias: Datos/estadísticas. https://www.paho.org/es/temas/abuso-sustancias.
Organización Mundial de la Salud (OMS). (2019a). WHO global report on trends in prevalence of tobacco use 2000-2025, third edition. Ginebra: Organización Mundial de la Salud.
Organización Mundial de la Salud (OMS). (2019b). Clasificación Internacional de Enfermedades, 11.a revisión. Descripciones Clínicas y pautas para el diagnóstico. Ginebra: Organización Mundial de la Salud.
Pacock, A.; Leung, J.; Larney, S.; Colledge, S.; Hickman, M.; Rehm, J.; Giovino, G.A.; West, R.; Hall, W. y Griffiths, P. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction 2018; 113, 1905–1926.
Piazza, P. V. y Deroche-Gamonet, V. (2013). A multistep general theory of transition to addiction. Psychopharmacology, 229(3), 387-413. doi: 10.1007/s00213-013-3224-4
Quigley, J. A., Logsdon, M. K., Turner, C. A., Gonzalez, I. L., Leonardo, N. B. y Becker, J. B. (2021). Sex differences in vulnerability to addiction. Neuropharmacology, 187, 108491. doi: 10.1016/j.neuropharm.2021.108491
Riesco Miranda, J. A. (2007). Efectos “no respiratorios” del tabaco. Archivos de Bronconeumología, 43(9), 477-478. doi: 10.1157/13109466
Rojas-Carvajal, M., Sequeira-Cordero, A. y Brenes, J. C. (2021). The environmental enrichment model revisited: A translatable paradigm to study the stress of our modern lifestyle. The European Journal of Neuroscience. doi: 10.1111/ejn.15160.
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., … & Abdollahpour, I. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1736-1788″
Scofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., … Kalivas, P. W. (2016). The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis. Pharmacological Reviews, 68(3), 816-871. doi: 10.1124/pr.116.012484
Sequeira-Cordero, A. y Brenes, J. C. (2021). Time-dependent changes in striatal monoamine levels and gene expression following single and repeated amphetamine administration in rats. European Journal of Pharmacology, 904, 174148. doi: 10.1016/j.ejphar.2021.174148
Siegel, R. K. (2005). Intoxication: the universal drive for mind-altering substances. Rochester: Park Street Press.
Tomasi, D. y Volkow, N. D. (2013). Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Critical Reviews in Biochemistry and Molecular Biology, 48(1), 1-19. doi: 10.3109/10409238.2012.735642
United Nations (UN). (2021). World drug report 2021. https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html
Volkow, N. D., Koob, G. F. y McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. The New England Journal of Medicine, 374(4), 363-371. doi: 10.1056/NEJMra1511480
Volkow, N. D., Michaelides, M. y Baler, R. (2019). The Neuroscience of Drug Reward and Addiction. Physiological Reviews, 99(4), 2115-2140. doi: 10.1152/physrev.00014.2018
Wemm, S. E. y Sinha, R. (2019). Drug-induced stress responses and addiction risk and relapse. Neurobiology of Stress, 10, 100148. doi: 10.1016/j.ynstr.2019.100148
Wenzel, J. M. y Cheer, J. F. (2018). Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling. Neuropsychopharmacology, 43(1), 103-115. doi: 10.1038/npp.2017.126
Witteman, J., Post, H., Tarvainen, M., de Bruijn, A., de Sousa Fernandes Perna, E., Ramaekers, J. G. y Wiers, R. W. (2015). Cue reactivity and its relation to craving and relapse in alcohol dependence: a combined laboratory and field study. Psychopharmacology, 232(20), 3685-3696. doi: 10.1007/s00213-015-4027-6